Skip to main content

Table 1 Correlation between ALX4 expression and clinical parameters from TMA data

From: ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway

   ALX4 expression  
Clinical parameter Total High Low P value
Clinical stages     0.012
I 11 9 2  
II 81 21 60  
III 48 12 36  
Histological grade     0.638
1 35 9 26  
2 106 33 73  
3 1 0 1  
Lymph node status     0.000
Negative 50 25 25  
Positive 88 17 71  
Tumor size     0.016
< 3 cm 48 21 27  
3 cm 93 21 72  
Her2     0.264
Positive 43 16 27  
Negative 88 24 64  
PR     0.058
Positive 77 19 58  
Negative 52 21 31  
ER     0.975
Positive 88 27 61  
Negative 42 13 29